Renal manifestations of primary mitochondrial disorders (Review)

  • Authors:
    • Josef Finsterer
    • Fulvio Scorza
  • View Affiliations

  • Published online on: April 12, 2017     https://doi.org/10.3892/br.2017.892
  • Pages: 487-494
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present review was to summarize and discuss previous findings concerning renal manifestations of primary mitochondrial disorders (MIDs). A literature review was performed using frequently used databases. The study identified that primary MIDs frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or in the later course of the MID. Occasionally, the kidneys are affected in MIDs. Renal manifestations of MIDs include renal insufficiency, nephrolithiasis, nephrotic syndrome, renal cysts, renal tubular acidosis, Bartter‑like syndrome, Fanconi syndrome, focal segmental glomerulosclerosis, tubulointerstitial nephritis, nephrocalcinosis, and benign or malign neoplasms. Among the syndromic MIDs, renal involvement has been most frequently reported in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke‑like episodes syndrome, Kearns‑Sayre syndrome, Leigh syndrome and mitochondrial depletion syndromes. Only in single cases was renal involvement also reported in chronic progressive external ophthalmoplegia, Pearson syndrome, Leber's hereditary optic neuropathy, coenzyme‑Q deficiency, X‑linked sideroblastic anemia and ataxia, myopathy, lactic acidosis, and sideroblastic anemia, pyruvate dehydrogenase deficiency, growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death, and hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis syndrome. The present study proposes that the frequency of renal involvement in MIDs is probably underestimated. Diagnosis of renal involvement follows general guidelines and treatment is symptomatic. Thus, renal manifestations of primary MIDs require recognition and appropriate management, as they determine the outcome of MID patients.
View References

Related Articles

Journal Cover

May-2017
Volume 6 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Finsterer J and Finsterer J: Renal manifestations of primary mitochondrial disorders (Review). Biomed Rep 6: 487-494, 2017
APA
Finsterer, J., & Finsterer, J. (2017). Renal manifestations of primary mitochondrial disorders (Review). Biomedical Reports, 6, 487-494. https://doi.org/10.3892/br.2017.892
MLA
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6.5 (2017): 487-494.
Chicago
Finsterer, J., Scorza, F."Renal manifestations of primary mitochondrial disorders (Review)". Biomedical Reports 6, no. 5 (2017): 487-494. https://doi.org/10.3892/br.2017.892